Suxamethonium in clinical practice (original) (raw)

Factors Affecting Magnitude and Time Course of Neuromuscular Block Produced by Suxamethonium

BJA: British Journal of Anaesthesia, 1992

Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine

Stephen Macres

British Journal of Anaesthesia, 1996

View PDFchevron_right

Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium

Neal Fleming

BJA: British Journal of Anaesthesia, 1994

View PDFchevron_right

Muscle pains and biochemical changes following suxamethonium administration after six pretreatment regimens

Peter Elliott

Anaesthesia, 1992

View PDFchevron_right

Myotonic and Neuromuscular Blocking Effects of Increased Doses of Suxamethonium in Infants and Children

oliver dearlove

BJA: British Journal of Anaesthesia, 1990

View PDFchevron_right

Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding Agent

Ignace Demeyer

Anesthesiology, 2007

View PDFchevron_right

Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation

leo booij

British Journal of Anaesthesia, 2006

View PDFchevron_right

Update on the management of neuromuscular block: focus on sugammadex

hans de boer

Neuropsychiatric Disease and Treatment

View PDFchevron_right

Succinylcholine: still beautiful and mysterious after all these years

Alain Li-Wan-Po

Journal of Clinical Pharmacy and Therapeutics, 2005

View PDFchevron_right

Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex

Sorin Brull

Drug Design, Development and Therapy, 2009

View PDFchevron_right

Pharmacology of G-1-64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action

Nguyen Vuong Khoi Nguyen

Acta Anaesthesiologica Scandinavica, 1999

View PDFchevron_right

Reversal of Profound Neuromuscular Block by Sugammadex Administered Three Minutes after Rocuronium

Keith Candiotti

Anesthesiology, 2009

View PDFchevron_right

Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey

leo booij

British Journal of Anaesthesia, 2006

View PDFchevron_right

Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia

Jean-Pierre Tétrault

Canadian Journal of Anaesthesia, 1998

View PDFchevron_right

The response of animals to suxamethonium (succinyldicholine) and succinylmonocholine

Neville Pitts

Journal of the South African Veterinary Association, 1991

View PDFchevron_right

Reversal of Rocuronium-induced (1.2 mg/kg) Profound Neuromuscular Block by Sugammadex

Marco Marcus

Anesthesiology, 2007

View PDFchevron_right

Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine???Glycopyrrolate and Edrophonium???Atropine

Kevin Klein

Anesthesia & Analgesia, 2007

View PDFchevron_right

Effect of suxamethonium on the auditory evoked response in humans

Caroline Doré

British Journal of Anaesthesia, 1996

View PDFchevron_right

Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept

hans de boer

Seminars in Anesthesia, Perioperative Medicine and Pain, 2002

View PDFchevron_right

Sugammadex: A revolutionary drug in neuromuscular pharmacology

Hemanth Kumar

Anesthesia: Essays and Researches, 2013

View PDFchevron_right

Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium-induced Neuromuscular Block in Patients Pretreated with Intravenous Magnesium

Nadia Elia

Anesthesiology, 2014

View PDFchevron_right

INFLUENCE OF SUXAMETHONIUM ON THE POTENCY OF ORG NC 45 IN ANAESTHETIZED PATIENTS

hans hendrickx

British Journal of Anaesthesia, 1981

View PDFchevron_right

Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1)

Markus Klimek

British Journal of Anaesthesia, 2007

View PDFchevron_right

Duration of stabilization of control responses affects the onset and duration of action of rocuronium but not suxamethonium

Nanda Kumar

European Journal of Anaesthesiology, 1996

View PDFchevron_right

Effects of Intracerebroventricular Sugammadex Administration on Central Nervous System in Rats

Hale Aksu Erdost

Brain Disorders & Therapy, 2016

View PDFchevron_right

Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane

A. Kalmar

View PDFchevron_right

Variability in the effect of muscle relaxants Factors involved

leo booij

View PDFchevron_right

Reversal of Deep Pipecuronium-Induced Neuromuscular Block With Moderate Versus Standard Dose of Sugammadex

Bela Fulesdi

Anesthesia & Analgesia

View PDFchevron_right

Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants

C. McDonald-Kerr

Anaesthesia, 1998

View PDFchevron_right

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study

Bela Fulesdi

BMC Anesthesiology

View PDFchevron_right

Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex

hans de boer

Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2008

View PDFchevron_right

Suxamethonium in clinical practice (original) (raw)

Related papers